| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d48f8c03b846acfb609b826f1a9f3e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080459845c1e6af459dd8cc7d289c4ac |
| publicationDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7745132-B1 |
| titleOfInvention |
Prognostic indicators of canine lymphoid neoplasia using tumor-derived plasma DNA |
| abstract |
A method of identifying an animal having a disease or condition without clinical symptoms includes detecting an elevated level of plasma DNA from blood or a blood fraction from the animal. In particular, the disease or condition can be a lymphoid neoplastic disease. Also, the plasma DNA can comprise a tumor-derived plasma DNA. In certain embodiments, the evaluation of the blood or blood fraction from the animal for the mutation assists in the identification of the disease or condition and/or its prognosis in the animal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2758538-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11161087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023106415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114606316-A |
| priorityDate |
2006-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |